|
471 |
Relationships between individual sensitivity to CS- and cocaine-induced reinstatement in the rat
Enthalten in Psychopharmacology Bd. 168, 13.2.2003, Nr. 1-2, date:7.2003: 201-207
|
|
|
|
472 |
Relationships of drinking and smoking with peripheral arterial stiffness in Chinese community-dwelling population without symptomatic peripheral arterial disease
Enthalten in Tobacco induced diseases Bd. 15, 25.10.2017, Nr. 1, date:12.2017: 1-5
|
|
|
|
473 |
Risk factors for addiction among patients receiving prescribed opioids: a systematic review protocol
Enthalten in Systematic Reviews Bd. 6, 28.12.2017, Nr. 1, date:12.2017: 1-8
|
|
|
|
474 |
Roadside opioid testing of drivers using oral fluid: the case of a country with a zero tolerance law, Spain
Enthalten in Substance abuse treatment, prevention, and policy Bd. 12, 10.5.2017, Nr. 1, date:12.2017: 1-7
|
|
|
|
475 |
Role of the hypothalamic-pituitary-adrenal axis in reinstatement of cocaine-seeking behavior in squirrel monkeys
Enthalten in Psychopharmacology Bd. 168, 22.3.2003, Nr. 1-2, date:7.2003: 177-183
|
|
|
|
476 |
Screening in Trauma for Opioid Misuse Prevention (STOMP): study protocol for the development of an opioid risk screening tool for victims of injury
Enthalten in Addiction science & clinical practice Bd. 12, 4.12.2017, Nr. 1, date:12.2017: 1-9
|
|
|
|
477 |
Screening, treatment initiation, and referral for substance use disorders
Enthalten in Addiction science & clinical practice Bd. 12, 7.8.2017, Nr. 1, date:12.2017: 1-4
|
|
|
|
478 |
Secondhand smoke exposure at home among middle and high school students in the United States – does the type of tobacco product matter?
Enthalten in BMC public health Bd. 17, 19.1.2017, Nr. 1, date:12.2017: 1-8
|
|
|
|
479 |
Selective inactivation of the dorsomedial prefrontal cortex and the basolateral amygdala attenuates conditioned-cued reinstatement of extinguished cocaine-seeking behavior in rats
Enthalten in Psychopharmacology Bd. 168, 5.9.2002, Nr. 1-2, date:7.2003: 57-65
|
|
|
|
480 |
Self-Injuring Behavior and Mental Illness in Opioid-Dependent Patients Treated with Implant Naltrexone, Methadone, and Buprenorphine in Western Australia
Enthalten in International journal of mental health and addiction Bd. 16, 20.12.2017, Nr. 1, date:2.2018: 187-198
|
|
Administration
